Transduction of primary hepatocytes with the PNPLA3 148M variant resulted in the upregulation of CXC chemokines and created a tumorigenic milieu upon lipid stimulation [38], linking this genetic variant not only to NASH but also to HCC development. Here, PNPLA3 is linked to metabolic dysfunction-associated steatohepatitis.